Pilulka's Market Expansion and Innovation

1.1 SECONDARY PUBLIC OFFERING OF PILULKA'S SHARES Date of the SPO 8.6.-22.6.2023 ISIN: CZ0009009874 Bloomberg: PINK CP Equity Thomson Reuters: PINK.PR START + Number of offer shares: up to 500,000 + + Price range: CZK 450-550 per share Expected market cap of the Company (100%): CZK 1,359m-1,662m (1) + Size of 1 lot: 10 shares (2) As part of the SPO, which takes place in the form of a public offering through the START Market of the Prague Stock Exchange, the Company offers for subscription new shares of an indicative volume of up to 500,000 (the total number of shares before the SPO is 2,520,934). The SPO does not include the sale of existing shares in the Company by current shareholders Further information on the SPO is provided in the Company's Prospectus for equity securities, which has been approved by the Czech National Bank and published on Pilulka's websites. Investors are also provided with a research report prepared by an authorized analyst Petr and Martin Kasa, the founders and key managers of the Company, will continue to manage and develop Pilulka. They will continue to be Pilulka's largest shareholders even after the SPO The funds raised from the subscription of offer shares (in an indicative amount of CZK 225m-275m(3), before transaction costs) will be used to further develop the Company, specifically to strengthen the Company's activities on foreign markets (mainly in Austria and Hungary), to further develop own e-health solutions, to strengthen the working capital and for potential acquisitions in the Czech Republic and abroad Pilulka is seeking a prospective listing of its shares on the regulated market of the Prague Stock Exchange. Following its gradual strengthening on foreign markets, Pilulka is taking steps to make its shares attractive and available also to foreign investors - the Prospectus was prepared in English, regular reporting to shareholders is bilingual in Czech and English, the Company aims to adopt International Financial Reporting Standards (IFRS) in the future, amongst other things Note: (1) i.e., the value of 100% of the Company's shares after subscription of 500k offer shares (2) Subject to the final SPO price, it corresponds to the value of CZK 4,500-5,500 (3) Assuming subscription of 500k offer shares within the price range of CZK 450-550 4 +pilulka

View entire presentation